Hair loss treatment is a global, multibillion dollar industry. To date, two “hair loss drugs” — finasteride and minoxidil — have been approved by Food and Drug Administration (FDA). Nevertheless, their use is limited because of potential side effects such as impotence, abnormal ejaculation, decreased ejaculatory volume, abnormal sexual function, gynecomastia, testicular pain, impairment of muscle growth, severe myopathy, hirsutism, local irridation, itching, dryness, erythema, dizziness and tachycardia, as well as unsatisfactory cure rates (
3,
4 and
27-
30). On the other hand, natural products with possible health benefits have been more and more appealing and about 1000 kinds of plant extracts have been examined with respect to hair growth (
3). For this purpose, we – to our knowledge, for the first time – investigated the angiogenic/antiangiogenic potential and cytotoxicity of
D. staphisagria seeds on epidermal keratinocytes (HaCaT) and endothelial cells (HUVECs). These seeds have traditionally been used for a variety of medical purposes. Previous phytochemical studies on the genus Delphinium have reported the presence of diterpenoid alkaloids, flavonoids, sterols and aliphatic acids, respectively, among which diterpenoid alkaloids are considered to be the main characteristic constituents (
8,
9,
31 and
32). Burmistrowa
et al. (2011), report that the flavonoid derivative astragalin heptaacetate (AHA), which was isolated from the aerial parts of
D. staphisagria, induces cell death in human HL-60 leukemia cell line (
33). Several studies aimed to identify potential plants that could be harnessed to design new therapies for neurological disorders and neurodegenerative diseases. They reported that the alkaloid delphinine (diterpene alkaloid), which is found in the seeds, has a structure similar to that of aconitine and possesses highly toxic effects on the central nervous system. However, there is no study to explain its hair-promoting effects despite its known insecticide, hydrops, purgative and emetic effects (
10,
11 and
34). In our study, we prepared vinegar and water extract from
D. staphisagria seeds according to the traditional usage and our results showed that there is no toxicity in either keratinocytes or endothelial cells even at high concentrations.
It is important to block apoptosis of hair follicle keratinocytes and to inhibit exogen phase for therapies of hair loss (
17,
35). Additionally, the vascular network is tightly correlated with the hair growth (
4) due to the activity of VEGF that is present in hair follicles, sebaceous glands, dermal papilla cell, keratinocytes and also other mesenchymal cells. Given that the growing hair follicle is surrounded by blood vessels (
4,
18,
20 and
36-
38), improving angiogenesis may be a key factor for the treatment of hair loss or promoting hair growth. It is known that minoxidil efficacy manifests via dilated blood vessels that effectively nourishes the surrounding hair bulbs and induces VEGF expression (
39,
40). On top of these effects on endothelial cells, minoxidil stimulates keratinocyte cell proliferation at micromolar doses (
41,
42). Based on the hypothesis that angiogenesis during the anagen growth might be associated with endothelial cell proliferation, we applied the matrigel tube formation assay on human endothelial cell to demonstrate the angiogenic potential of
D. staphisagria seeds. When the endothelial cells are plated on a layer of basement membrane
in-vitro, they attach, migrate and form capillary like structures with a lumen in 12 h (
43). We assessed the changes in standard morphological criteria of angiogenesis (microvessel density, vessel calibers, and the number of endothelial cell nuclei) and in number of proliferating endothelial cells qualitatively and quantitatively in defined reference areas throughout the hair cycle (
19). Our cytotoxicity results present an idea about the number of proliferating endothelial cells. Up to 250 μg/mL concentration, cell number did not change significantly at 24 h when compared to the control group in vinegar extract. And, importantly, seeds of
D. staphisagria at a dose of 1, 10, 20, 40, 80, 100, 120, 200 and 250 μg/mL increased the proliferation of HUVECs to 20% as compared to the control treatment at 48 h. Water extract did not cause inhibition of endothelial and keratinocyte cells proliferation at both time points in all applied concentrations.
While angiogenesis has traditionally been defined as the growth of new capillaries from preexisting vessels, it has recently been proposed that a second type of angiogenesis (“remodeling type”) involves enlargement and elongation of preexisting vessels (
43). Our results showed that a capillary-like tube network of HUVECs was formed in the control group, and beyond 20 µg/mL ESDS led to markedly induced tube formation in the same culture conditions (i.e., increased tube length and number of branches). We saw expansion of tubes in the ESDS-treated group in a dose-dependent manner. At non-cytotoxic concentrations of 20 and 300 μg/mL, HUVECs induced capillary vessel formation in culture (
Figure 2). We therefore argue that
D. staphisagria initially stimulates endothelial cell proliferation and angiogenesis, and then specific signal mechanisms VEGF are transduced to dermal components of the skin and hair growth is stimulated.